USPTO serial 79275190
RETRONOSE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 23, 2021
- Examiner
- OSGOOD, KRYSTINA E
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with RETRONOSE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
TOURS CEDEX 01, FR
LA DIFFUSION TECHNIQUE FRANCAISE
SAINT-ETIENNE, FR
LA DIFFUSION TECHNIQUE FRANCAISE
SAINT-ETIENNE, FR
LA DIFFUSION TECHNIQUE FRANCAISE
SAINT-ETIENNE, FR
TOURS CEDEX 01, FR
TOURS CEDEX 01, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Janet G Ricciuti
Janet G Ricciuti JANET GILBERT RICCIUTI1830 S STREET NWWASHINGTON, DC 20009UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products, namely, medicines and chemical preparations for medical use for the treatment of immune system related diseases and disorders, for treating or preventing of respiratory diseases and disorders, of infectious diseases, of inflammation, of upper airways cancer diseases, of radioactive contamination, of biohazard contamination, of pain, central nervous system diseases, cardiovascular diseases, metabolic diseases, of asthma, of allergies; vaccines; Medicines for medical use for the treatment of immune system related diseases and disorders, for treating or preventing of respiratory diseases and disorders, of infectious diseases, of inflammation, of upper airways cancer diseases, of radioactive contamination, of biohazard contamination, of pain, central nervous system diseases, cardiovascular diseases, metabolic diseases, of asthma, of allergies; vaccines for humans; Chemical preparations for medical use, namely, for the treatment of immune system related diseases and disorders, for treating or preventing of respiratory diseases and disorders, of infectious diseases, of inflammation, of upper airways cancer diseases, of radioactive contamination, of biohazard contamination, of pain, central nervous system diseases, cardiovascular diseases, metabolic diseases, of asthma, of allergies; vaccines; Chemical preparations for pharmaceutical use, namely, for the treatment of immune system related diseases and disorders, for treating or preventing of respiratory diseases and disorders, of infectious diseases, of inflammation, of upper airways cancer diseases, of radioactive contamination, of biohazard contamination, of pain, central nervous system diseases, cardiovascular diseases, metabolic diseases, of asthma, of allergies; vaccines | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely, surgical apparatus and instruments for use in general and minimally invasive surgery; Apparatus for distribution, dosage and administration of medical products, namely, aerosol dispensers and inhalers, dry powder inhalers, nebulizers, pressurized metered dose inhalers, soft mist inhalers all for medical purposes; Apparatus for distribution, dosage and administration of pharmaceutical products, namely, aerosol dispensers and inhalers, dry powder inhalers, nebulizers, pressurized metered dose inhalers, soft mist inhalers all for medical use; Apparatus in the nature of inhalers and nebulizers for administering aerosols all for medical use; Apparatus actuated by nasal expiratory phase for administering sprays for medical use, namely, nasal aspirators; Inhalers and apparatus actuated by nasal expiratory phase, namely, nasal aspirators for administering medicines for nasal, rhinological, laryngeal and oral cavity effect | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by UNIVERSITE DE TOURS
- Other trademarks owned by LA DIFFUSION TECHNIQUE FRANCAISE
- Other trademarks owned by LA DIFFUSION TECHNIQUE FRANCAISE
- Other trademarks owned by LA DIFFUSION TECHNIQUE FRANCAISE
- Other trademarks owned by UNIVERSITE DE TOURS
- Other trademarks owned by UNIVERSITE DE TOURS
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named RETRONOSE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 23, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 24, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 26, 2021 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| May 26, 2021 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| May 23, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 23, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 8, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 8, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 6, 2020 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 18, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 18, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 18, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 4, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 4, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 4, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 4, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 4, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 13, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 13, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 13, 2020 | ALIE | ASSIGNED TO LIE | — |
| Sep 1, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 21, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 5, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 5, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 12, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 11, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 11, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 10, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 6, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 26, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |